Skip Header

You are using a version of browser that may not display all the features of this website. Please consider upgrading your browser.
1 to 20 of 20  Show

Literature citations Results

Citation
Targeted PPAR{gamma} deficiency in alveolar macrophages disrupts surfactant catabolism.

Baker A.D., Malur A., Barna B.P., Ghosh S., Kavuru M.S., Malur A.G., Thomassen M.J.

J. Lipid Res. 51:1325-1331(2010) · Mapped (14)

Restoration of PPARgamma reverses lipid accumulation in alveolar macrophages of GM-CSF knockout mice.

Malur A., Baker A.D., McCoy A.J., Wells G., Barna B.P., Kavuru M.S., Malur A.G., Thomassen M.J.

Am. J. Physiol. Lung Cell Mol. Physiol. 300:L73-80(2011) · Mapped (15)

PU.1 regulation of human alveolar macrophage differentiation requires granulocyte-macrophage colony-stimulating factor.

Bonfield T.L., Raychaudhuri B., Malur A., Abraham S., Trapnell B.C., Kavuru M.S., Thomassen M.J.

Am. J. Physiol. Lung Cell Mol. Physiol. 285:L1132-6(2003) · Mapped (2)

PPARgamma regulates the expression of cholesterol metabolism genes in alveolar macrophages.

Baker A.D., Malur A., Barna B.P., Kavuru M.S., Malur A.G., Thomassen M.J.

Biochem. Biophys. Res. Commun. 393:682-687(2010) · Mapped (10)

Peroxisome proliferator-activated receptor-gamma regulates the expression of alveolar macrophage macrophage colony-stimulating factor.

Bonfield T.L., Thomassen M.J., Farver C.F., Abraham S., Koloze M.T., Zhang X., Mosser D.M., Culver D.A.

J. Immunol. 181:235-242(2008) · Mapped (30)

Peroxisome proliferator-activated receptor-gamma is deficient in alveolar macrophages from patients with alveolar proteinosis.

Bonfield T.L., Farver C.F., Barna B.P., Malur A., Abraham S., Raychaudhuri B., Kavuru M.S., Thomassen M.J.

Am. J. Respir. Cell Mol. Biol. 29:677-682(2003) · Mapped (13)

Lentivirus-ABCG1 instillation reduces lipid accumulation and improves lung compliance in GM-CSF knock-out mice.

Malur A., Huizar I., Wells G., Barna B.P., Malur A.G., Thomassen M.J.

Biochem. Biophys. Res. Commun. 415:288-293(2011) · Mapped (3)

Interleukin 10 (IL-10)-mediated inhibition of inflammatory cytokine production by human alveolar macrophages.

Raychaudhuri B., Fisher C.J., Farver C.F., Malur A., Drazba J., Kavuru M.S., Thomassen M.J.

Cytokine 12:1348-1355(2000) · Mapped (2)

Hepatic Steatosis Accompanies Pulmonary Alveolar Proteinosis.

Hunt A.N., Malur A., Monfort T., Lagoudakis P., Mahajan S., Postle A.D., Thomassen M.J.

Am. J. Respir. Cell Mol. Biol. 57:448-458(2017) · Mapped (3)

Eosinophil Peroxidase Catalyzed Protein Carbamylation Participates in Asthma.

Wang Z., DiDonato J.A., Buffa J., Comhair S.A., Aronica M.A., Dweik R.A., Lee N.A., Lee J.J., Thomassen M.J., Kavuru M. et al.

J. Biol. Chem. 291:22118-22135(2016) · Mapped (11)

Elevated IL-10 inhibits GM-CSF synthesis in pulmonary alveolar proteinosis.

Thomassen M.J., Raychaudhuri B., Bonfield T.L., Malur A., Abraham S., Barna B.P., Kavuru M.S.

Autoimmunity 36:285-290(2003) · Mapped (10)

Elevated gelatinase activity in pulmonary alveolar proteinosis: role of macrophage-colony stimulating factor.

Bonfield T.L., Swaisgood C.M., Barna B.P., Farver C.F., Kavuru M.S., Thomassen M.J.

J. Leukoc. Biol. 79:133-139(2006) · Mapped (3)

Differential induction of extracellular glutathione peroxidase and nitric oxide synthase 2 in airways of healthy individuals exposed to 100% O(2) or cigarette smoke.

Comhair S.A.A., Thomassen M.J., Erzurum S.C.

Am. J. Respir. Cell Mol. Biol. 23:350-354(2000) · UniProtKB (1)

Depressed peroxisome proliferator-activated receptor gamma (PPargamma) is indicative of severe pulmonary sarcoidosis: possible involvement of interferon gamma (IFN-gamma).

Barna B.P., Culver D.A., Abraham S., Malur A., Bonfield T.L., John N., Farver C.F., Drazba J.A., Raychaudhuri B., Kavuru M.S. et al.

Sarcoidosis Vasc Diffuse Lung Dis 23:93-100(2006) · Mapped (25)

Deletion of PPAR gamma in alveolar macrophages is associated with a Th-1 pulmonary inflammatory response.

Malur A., Mccoy A.J., Arce S., Barna B.P., Kavuru M.S., Malur A.G., Thomassen M.J.

J. Immunol. 182:5816-5822(2009) · Mapped (25)

Autoantibodies against granulocyte macrophage colony-stimulating factor are diagnostic for pulmonary alveolar proteinosis.

Bonfield T.L., Russell D., Burgess S., Malur A., Kavuru M.S., Thomassen M.J.

Am. J. Respir. Cell Mol. Biol. 27:481-486(2002) · Mapped (3)

Alveolar macrophages of GM-CSF knockout mice exhibit mixed M1 and M2 phenotypes.

Dalrymple H., Barna B.P., Malur A., Malur A.G., Kavuru M.S., Thomassen M.J.

BMC Immunol. 14:41-41(2013) · Mapped (3)

Alveolar macrophage cathelicidin deficiency in severe sarcoidosis.

Barna B.P., Culver D.A., Kanchwala A., Singh R.J., Huizar I., Abraham S., Malur A., Marshall I., Kavuru M.S., Thomassen M.J.

J Innate Immun 4:569-578(2012) · Mapped (21)

Alveolar macrophage activation in obese patients with obstructive sleep apnea.

Sharma S., Malur A., Marshall I., Huizar I., Barna B.P., Pories W., Dohm L., Kavuru M.S., Thomassen M.J.

Surgery 151:107-112(2012) · Mapped (13)

ABCG1 is deficient in alveolar macrophages of GM-CSF knockout mice and patients with pulmonary alveolar proteinosis.

Thomassen M.J., Barna B.P., Malur A.G., Bonfield T.L., Farver C.F., Malur A., Dalrymple H., Kavuru M.S., Febbraio M.

J. Lipid Res. 48:2762-2768(2007) · Mapped (8)

1 to 20 of 20  Show
UniProt is an ELIXIR core data resource
Main funding by: National Institutes of Health

We'd like to inform you that we have updated our Privacy Notice to comply with Europe’s new General Data Protection Regulation (GDPR) that applies since 25 May 2018.

Do not show this banner again